Publications by authors named "Axel Finckh"

Claim this Profile
T
The epidemiology of RA.
Axel Finckh

Nat Rev Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.
Maja Skov Kragsnaes, Benoit Thomas P Gilbert, Bjørk Khaliqi Sofíudóttir, Christopher Michael Rooney, Sebrina Maj-Britt Hansen, Axel Finckh

BMJ Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When borders impact science: what is the future of European rheumatology research?
Frank Verhoeven, Athan Baillet, Celine Demougeot, Xavier Romand, Daniel Wendling, Axel Finckh

Ann Rheum Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relatives.
Romain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert, Maresa Grundhuber, Isabel Gehring, Axel Finckh

RMD Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Axel Finckh

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations.
Andrea Pluma, Sabrina Hamroun, Linda Rüegg, Irene Cecchi, Malte Kramer, Axel Finckh

Ann Rheum Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update.
Linda Rüegg, Andrea Pluma, Sabrina Hamroun, Irene Cecchi, Luis Fernando Perez-Garcia, Axel Finckh

Ann Rheum Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotics in inflammatory arthritis and background population one year before and after diagnosis: a nationwide drug utilization study.
Maja S Kragsnaes, Nickolaj Risbo, Jens Kristian Pedersen, Niels Obel, Axel Finckh

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag, Juan Molina-Collada, Ramatoulaye Ndoye, Daniel Aletaha, Johan Askling, Axel Finckh

Ann Rheum Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.
Christoph D Spinner, Samira Bell, Hermann Einsele, Cécile Tremblay, Michel Goldman, Axel Finckh

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potential role for chlamydial infection in rheumatoid arthritis development.
Celine Lamacchia, Romain Aymon, Brian C Hattel, Sebastien Aeby, Carole Kebbi-Beghdadi, Axel Finckh

Rheumatology (Oxford)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag, Kim Lauper, Juan Molina-Collada, Daniel Aletaha, Johan Askling, Axel Finckh

Ann Rheum Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib as monotherapy for treatment of rheumatoid arthritis: analysis of real-world data.
Christoper J Edwards, Tsutomu Takeuchi, Axel Finckh, Arnd Kleyer, Ewa Haladyj

Curr Med Res Opin· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol.
Elisa Dalix, Christian Marcelli, Theodora Bejan-Angoulvant, Axel Finckh, Florence Rancon

BMJ Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention.
Janet Pope, Axel Finckh, Lucia Silva-Fernández, Peter Mandl, Haiyun Fan

Open Access Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases.
Cécile Trottet, Ahmed Allam, Aron N Horvath, Axel Finckh, Thomas Hügle

PLOS Digit Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis.
Denis Mongin, Sabrina Pagano, Celine Lamacchia, Catherine Juillard, Paola Antinori-Malaspina, Axel Finckh

Front Cardiovasc Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies.
Kim Lauper, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Axel Finckh

Joint Bone Spine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Axel Finckh

Ann Rheum Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA.
Benoit Thomas P Gilbert, Denis Mongin, Romain Aymon, Kim Lauper, Cédric Laedermann, Axel Finckh

BMJ Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort.
Lisa Christ, Seraphina Kissling, Axel Finckh, Benjamin A Fisher, Sabine Adler

Arthritis Res Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry.
Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden,

BMJ Open· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Rheumatology: what's new in 2023].
Kim Lauper, Axel Finckh, Stéphane Genevay, Charlotte Girard-Guyonvarc'h, Romain Guemara

Rev Med Suisse· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis.
Benoît Thomas P Gilbert, Raul Yhossef Tito Tadeo, Celine Lamacchia, Olivia Studer, Delphine Courvoisier, Axel Finckh

RMD Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis